Press Releases
Jan. 24, 2026
Belgium Bars All Israeli Arms Flights Through Its Territory
Indeterminate
MENAFN
Owner: Sawsan Dababneh & Ramzi AbdelJaber
Feb. 3, 2026
Rafah Border Crossing Reopens for Select Few Palestinians
Indeterminate
MENAFN
Owner: Sawsan Dababneh & Ramzi AbdelJaber
Jan. 8, 2026
Transformation Insights Announces Global Office in Tel Aviv, Israel
Neutral
EIN Presswire
Jan. 22, 2026
18,500 Gaza Patients in Critical Need of Medical Evacuation, WHO Says
Indeterminate
MENAFN
Owner: Sawsan Dababneh & Ramzi AbdelJaber
Jan. 22, 2026
UN says Gaza city water supply disrupted amid Israeli restrictions
Indeterminate
MENAFN
Owner: Sawsan Dababneh & Ramzi AbdelJaber
Jan. 21, 2026
ENvue Medical Appoints Industry Veteran Marc Waldman as Vice President, Commercial
Indeterminate
GlobeNewswire, Inc.
Jan. 13, 2026
Israel Begins Severing Power, Water to UNRWA Facilities
Indeterminate
MENAFN
Owner: Sawsan Dababneh & Ramzi AbdelJaber
Jan. 13, 2026
Israel cuts utilities to UNRWA facilities in East Jerusalem
Indeterminate
MENAFN
Owner: Sawsan Dababneh & Ramzi AbdelJaber
Jan. 13, 2026
Israel murders three Palestinians in new assaults on Gaza
Indeterminate
MENAFN
Owner: Sawsan Dababneh & Ramzi AbdelJaber
Jan. 21, 2026
WHO warns many in Gaza remain in need of urgent medical evacuation
Indeterminate
MENAFN
Owner: Sawsan Dababneh & Ramzi AbdelJaber
Jan. 20, 2026
UNRWA chief condemns Israeli raid on East Jerusalem headquarters
Indeterminate
MENAFN
Owner: Sawsan Dababneh & Ramzi AbdelJaber
Jan. 21, 2026
Gaza Bleeds: Nine Palestinians Killed in Israeli Strikes
Indeterminate
MENAFN
Owner: Sawsan Dababneh & Ramzi AbdelJaber
Jan. 21, 2026
Two Killed in Israeli Airstrikes in Southern Lebanon
Indeterminate
MENAFN
Owner: Sawsan Dababneh & Ramzi AbdelJaber
Jan. 20, 2026
Nasus Pharma Announces Positive Interim Results from Phase 2 Clinical Study of NS002 Intranasal Epinephrine Powder
Indeterminate
GlobeNewswire, Inc.
Jan. 20, 2026
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ultragenyx Pharmaceutical Inc. - RARE
Indeterminate
GlobeNewswire, Inc.
Jan. 20, 2026
*CORRECTION*INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inovio Pharmaceuticals, Inc. - INO
Indeterminate
GlobeNewswire, Inc.
Jan. 20, 2026
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Vanda Pharmaceuticals Inc. - VNDA
Indeterminate
GlobeNewswire, Inc.